Clinical Trials Browser

Phase 2 × Colonic Neoplasms × irinotecan sucrosofate × Clear all

NCT06643793 2025-01-28

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms